The immunological effects of taxanes

Cancer Immunology Immunotherapy

Volumn 49, Issue 4-5, 2000, Pages 181-185

  Chan, Owen T M ^a   Yang, Li Xi ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; Chemotherapy; Immune surveillance; Immunosuppression; Lipopolysaccharide mimetics

Indexed keywords

DOCETAXEL; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PACLITAXEL; TAXANE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOLOGY; HUMAN; IMMUNOMODULATION; IMMUNOSTIMULATION; IMMUNOSURVEILLANCE; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033942857     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620000122     Document Type: Review

References (61)

1. Abramson N, Castro S, Goldstein JD (1997) Lipid-laden macrophage infiltration of human adenocarcinoma in vivo associated with taxol and GCSF treatment. Cancer Invest 15: 18-22
2. Amato SF, Swart JM, Berg M, Wanebo HJ, Mehta SR, Chiles TC (1998) Transient stimulation of the c-Jun-NH2-terminal kinase/activator protein 1 pathway and inhibition of extra-cellular signal-regulated kinase are early effects in paclitaxel-mediated apoptosis in human B lymphoblasts. Cancer Res 58: 241-247
3. Aoyama M, MacIsaac D, Bukowski RM, Ganapathi MK (1998) Interleukin 6 differentially potentiates the antitumor effects of taxol and vinblastine in U266 human myeloma cells. Clin Cancer Res 4: 1039-1045
4. Arsenault AL, Lhotak S, Hunter WL, Banquerigo ML, Brahn E (1998) Taxol involution of collagen-induced arthritis: ultrastructural correlation with the inhibition of synovitis and neovascularization. Clin Immunol Immunopathol 86: 280-289
5. Bengala C, Pazzagli I, Tibaldi C, Favre C, Vanacore R, Greco F, Mazzoni A, Menconi MC, Macchia P, Conte PF (1998) Mobilization, collection, and characterization of peripheral blood hemopoietic progenitors after chemotherapy with epirubicin, paclitaxel, and granulocyte-colony stimulating factor administered to patients with metastatic breast carcinoma (see comments). Cancer 82: 867-873
6. Bhat N, Perera PY, Carboni JM, Blanco J, Golenbock DT, Mayadas TN, Vogel SN (1999) Use of a photoactivatable taxol analogue to identify unique cellular targets in murine macrophages: identification of murine CD18 as a major taxol-binding protein and a role for Mac-1 in taxol-induced gene expression. J Immunol 162: 7335-7342
7. Bissery MC (1995) Preclinical pharmacology of docetaxel. Eur J Cancer 31A[Suppl 4]: S1-S6
8. Bogdan C, Ding A (1992) Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages. J Leukoc Biol 52: 119-121
9. Brahn E, Tang C, Banquerigo ML (1994) Regression of collagen-induced arthritis with taxol, a microtubule stabilizer. Arthritis Rheum 37: 839-845
10. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72: 3666-3670
11. Chuang LT, Lotzova E, Cook KR, Cristoforoni P, Morris M, Wharton JT (1993) Effect of new investigational drug taxol on oncolytic activity and stimulation of human lymphocytes. Gynecol Oncol 49: 291-298
12. Chuang LT, Lotzova E, Heath J, Cook KR, Munkarah A, Morris M, Wharton JT (1994) Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol [published erratum appears in Cancer Res (1994) 54: 2523-2524]. Cancer Res 54: 1286-1291
13. Consolini R, Pui CH, Behm FG, Raimondi SC, Campana D (1998) In vitro cytotoxicity of docetaxel in childhood acute leukemias. J Clin Oncol 16: 907-913
14. Demirer T, Rowley S, Buckner CD, Appelbaum FR, Lilleby K, Storb R, Schiffman K, Bensinger WI (1995) Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer. J Clin Oncol 13: 1714-1719
15. Ding AH, Porteu F, Sanchez E, Nathan CF (1990) Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents. J Exp Med 171: 715-727
16. Ding AH, Porteu F, Sanchez E, Nathan CF (1990) Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 248: 370-372
17. Ding A, Sanchez E, Nathan CF (1993) Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinase. J Immunol 151: 5596-5602
18. Donaldson KL, Goolsby GL, Wahl AF (1994) Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int J Cancer 57: 847-855
19. Fennelly DW, Aghajanian C, Shapiro F, O'Flaherty C, O'Connor K, Curtin JP, Crown JP, Hoskins WJ, Spriggs DR (1997) Dose escalation of paclitaxel with high-dose carboplatin using peripheral blood progenitor cell support in patients with advanced ovarian cancer. Semin Oncol 24: S2-S2
20. Gianni AM, Siena S, Bregni M, Tarella C, Stern AC, Pileri A, Bonadonna G (1989) Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 2: 580-585
21. Grunberg E, Eckert K, Maurer HR (1998) Docetaxel treatment of HT-29 colon carcinoma cells reinforces the adhesion and immunocytotoxicity of peripheral blood lymphocytes in vitro. Int J Oncol 12: 957-963
22. Havell EA, Fiers W, North RJ (1988) The antitumor function of tumor necrosis factor (TNF). I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J Exp Med 167: 1067-1085
23. Henricson BE, Carboni JM, Burkhardt AL, Vogel SN (1995) LPS and Taxol activate Lyn kinase autophosphorylation in Lps(n), but not in Lpsd), macrophages. Mol Med 1: 428-435
24. Hortobagyi GN (1999) Recent progress in the clinical development of docetaxel (Taxotere). Semin Oncol 26: 32-36
25. Hui A, Kulkarni GV, Hunter WL, McCulloch CA, Cruz TF (1997) Paclitaxel selectively induces mitotic arrest and apoptosis in proliferating bovine synoviocytes. Arthritis Rheum 40: 1073-1084
26. Ingalls RR, Golenbock DT (1995) CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J Exp Med 181: 1473-1479
27. Jin F, Nathan CF, Radzioch D, Ding A (1998) Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor. Infect Immun 66: 2447-2452
28. Lavelle F, Bissery MC, Combeau C, Riou JF, Vrignaud P, Andre S (1995) Preclinical evaluation of docetaxel (Taxotere). Semin Oncol 22: 3-16
29. Lee JD, Kravchenko V, Kirkland TN, Han J, Mackman N, Moriarty A, Leturcq D, Tobias PS, Ulevitch RJ (1993) Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc Natl Acad Sci USA 90: 9930-9934
30. Lee LF, Schuerer-Maly CC, Lofquist AK, Haaften-Day C van, Ting JP, White CM, Martin BK, Haskill JS (1996) Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer. Cancer Res 56: 1303-1308
31. Lee LF, Haskill JS, Mukaida N, Matsushima K, Ting JP (1997) Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter. Mol Cell Biol 17: 5097-5105
32. Lin CK, Nguyen TT, Morgan TL, Mei RL, Kaptein JS, Kalunta CI, Yen CF, Park E, Zou HY, Lad PM (1998) Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM. Exp Cell Res 244: 1-13
33. Manfredi JJ, Parness J, Horwitz SB (1982) Taxol binds to cellular microtubules. J Cell Biol 94: 688-696
34. Mangatal L, Adeline M-T, Guenard D, Gueritte-Voegelein F, Potier P (1989) Application of the vicinal oxyamination reaction with asymmetric induction to the hemisynthesis of taxol and analogues. Tetrahedron 45: 4177-4190
35. Manthey CL, Brandes ME, Perera PY, Vogel SN (1992) Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages. J Immunol 149: 2459-2465
36. Manthey CL, Qureshi N, Stutz PL, Vogel SN (1993) Lipopolysaccharide antagonists block taxol-induced signaling in murine macrophages. J Exp Med 178: 695-702
37. Manthey CL, Perera PY, Salkowski CA, Vogel SN (1994) Taxol provides a second signal for murine macrophage tumoricidal activity. J Immunol 152: 825-831
38. Milas L, Hunter NR, Mason KA, Kurdoglu B, Peters LJ (1994) Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res 54: 3506-3510
39. Moos PJ, Muskardin DT, Fitzpatrick FA (1999) Effect of taxol and taxotere on gene expression in macrophages: induction of the prostaglandin H synthase-2 isoenzyme. J Immunol 162: 467-473
40. Mullins DW, Burger CJ, Elgert KD (1999) Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide. J Immunol 162: 6811-6818
41. Munkarah A, Chuang L, Lotzova E, Cook K, Morris M, Wharton JT (1994) Comparative studies of taxol and taxotere on tumor growth and lymphocyte functions. Gynecol Oncol 55: 211-216
42. North RJ, Havell EA (1988) The antitumor function of tumor necrosis factor (TNF) II. Analysis of the role of endogenous TNF in endotoxin-induced hemorrhagic necrosis and regression of an established sarcoma. J Exp Med 167: 1086-1099
43. Parness J, Horwitz SB (1981) Taxol binds to polymerized tubulin in vitro. J Cell Biol 91: 479-487
44. Perera PY, Qureshi N, Vogel SN (1996) Paclitaxel (Taxol)-induced NF-kappaB translocation in murine macrophages. Infect Immun 64: 878-884
45. Perera PY, Vogel SN, Detore GR, Haziot A, Goyert SM (1997) CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. J Immunol 158: 4422-4429
46. Pluznik DH, Bickel M, Mergenhagen SE (1989) B lymphocyte derived hematopoietic growth factors. Immunol Invest 18: 103-116
47. Pluznik DH, Lee NS, Sawada T (1994) Taxol induces the hematopoietic growth factor granulocyte-macrophage colony-stimulating factor in murine B-cells by stabilization of granulocyte-macrophage colony-stimulating factor nuclear RNA. Cancer Res 54: 4150-4154
48. Prince HM, Gardyn J, Millward MJ, Rischin D, Francis P, Gates P, Chapple P, Quinn M, Juneja S, Wolf M, Januszewicz EH, Richardson G, Scarlett J, Briggs P, Brettell M, Toner GC (1999) Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer. Bone Marrow Transplant 23: 427-435
49. Rao P, Falk LA, Dougherty SF, Sawada T, Pluznik DH (1997) Colchicine down-regulates lipopolysaccharide-induced granulocyte-macrophage colony-stimulating factor production in murine macrophages. J Immunol 159: 3531-3539
50. Ringel I, Horwitz SB (1991) Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst 83: 288-291
51. Rowinsky EK, Onetto N, Canetta RM, Arbuck SG (1992) Taxol: the first of the taxanes, an important new class of antitumor agents. Semin Oncol 19: 646-662
52. Schiff PB, Fant J, Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277: 665-667
53. Song YW, Kim HA, Baek HJ, Lee EB, Chung ES, Hong KM (1998) Paclitaxel reduces anti-dsDNA antibody titer and BUN, prolonging survival in murine lupus. Int J Immunopharmacol 20: 669-677
54. Spencer CM, Faulds D (1994) Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs 48: 794-847
55. Tominaga K, Kirikae T, Nakano M (1997) Lipopolysaccharide (LPS)-induced IL-6 production by embryonic fibroblasts isolated and cloned from LPS-responsive and LPS-hyporesponsive mice. Mol Immunol 34: 1147-1156
56. Ulevitch RJ, Tobias PS (1995) Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13: 437-457
57. Verma UN, van den Blink B, Pillai R, Chawla J, Mazumder A, Herscowitz HB, Meehan KR (1999) Paclitaxel vs cyclophosphamide in peripheral blood stem cell mobilization: comparative studies in a murine model. Exp Hematol 27: 553-560
58. Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT (1971) Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 5 93: 2325-2327
59. White CM, Martin BK, Lee LF, Haskill JS, Ting JP (1998) Effects of paclitaxel on cytokine synthesis by unprimed human monocytes, T lymphocytes, and breast cancer cells. Cancer Immunol Immunother 46: 104-112
60. Wolfson M, Yang CP, Horwitz SB (1997) Taxol induces tyrosine phosphorylation of She and its association with Grb2 in murine RAW 264.7 cells. Int J Cancer 70: 248-252
61. Zaks-Zilberman M, Salkowski CA, Elsasser T, Cuttitta F, Vogel SN (1998) Induction of adrenomedullin mRNA and protein by lipopolysaccharide and paclitaxel (Taxol) in murine macrophages. Infect Immun 66: 4669-4675